newsfilter
← Latest News
GlobeNewswire·

Dianthus Therapeutics to Participate in Five Investor Conferences During November

  • Dianthus Therapeutics, Inc. (NASDAQ: DNTH) announced participation in five investor conferences.
  • CEO Marino Garcia will participate in fireside chats at the Guggenheim 3rd Annual Healthcare Innovation Conference on Nov 9, Stifel 2026 Healthcare Conference on Nov 11, UBS Global Biopharma Conference on Nov 16, 2026, 9:20 a.m. GMT, 2026 Jefferies Global Healthcare Conference on Nov 18, 2026, 2:30 p.m. GMT.
  • CFO 2026 Truist Securities BioPharma Symposium meetings will be hosted by EVP Ryan Savitz on Nov 12.
  • One-on-one investor meetings with Marino Garcia 2026 Ryan Savitz will be available at the Guggenheim, Stifel, UBS, 2026 Jefferies, 2026 Truist conferences.
  • Webcasts of the fireside chats will be accessible under "News 2026 Events" in the Investors section of the company website.
  • Dianthus Therapeutics is a clinical-stage biotechnology company based in New York City 2026 Waltham, Mass., focused on next-generation therapies for severe autoimmune diseases.